Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
about
Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markersThe role of aflibercept in the management of diabetic macular edemaGlucose, VEGF-A, and diabetic complicationsA systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use.Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatmentSerum-dependence of affinity-mediated VEGF release from biomimetic microspheresEffects of laser photocoagulation on serum angiopoietin-1, angiopoietin-2, angiopoietin-1/angiopoietin-2 ratio, and soluble angiopoietin receptor Tie-2 levels in type 2 diabetic patients with proliferative diabetic retinopathy.Association between vascular endothelial growth factor and hypertension in children and adolescents type I diabetes mellitus.Effect of pan-retinal laser photocoagulation on plasma VEGF, endothelin-1 and nitric oxide in PDR.Vital exhaustion and retinal microvascular changes in cardiovascular disease: atherosclerosis risk in communities study.Vitreous and plasma VEGF levels as predictive factors in the progression of proliferative diabetic retinopathy after vitrectomyPlasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma.VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP.Sugar creates a sticky business: round up the usual suspects.Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro.VEGF levels in plasma in relation to platelet activation, glycemic control, and microvascular complications in type 1 diabetes.Differential regulation of angiogenesis using degradable VEGF-binding microspheres.Both vascular endothelial growth factor and soluble Flt-1 are increased in type 2 diabetes but not in impaired fasting glucose.The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy.Endothelial cell-oligodendrocyte interactions in small vessel disease and agingImpaired Neovascularization and Reduced Capillary Supply in the Malignant vs. Non-malignant Course of Experimental Renovascular HypertensionRole of Angiopoietins and Tie-2 in Diabetic Retinopathy.Plasma levels of IL-17, VEGF, and adrenomedullin and S-cone dysfunction of the retina in children and adolescents without signs of retinopathy and with varied duration of diabetes.Plasma levels of hypoxia-regulated factors in patients with age-related macular degeneration.
P2860
Q24644869-24687E42-0B7E-4322-BE76-6C8AF70C6B27Q26798348-46BE046E-2BC5-4408-8053-14D61B5C099FQ28362039-0758E4C8-6D40-44E3-9CA0-BA19DDA55D08Q30433214-6C6CB518-3828-4704-92F0-4A1915AD5C1AQ33209039-60859B26-7D7C-4D16-8B71-5EAAA4CC5872Q33217407-8CB2DC93-5A03-41D7-B167-84FB30EC6DDFQ33761778-481A25BF-4D11-47E7-A2ED-5A053545987CQ34063056-83E81D34-D1FD-466C-BD92-175B93F90D54Q34239673-1202F887-0097-4DBF-9D8A-F91B0A0EC512Q34254444-7ED9ABF3-039B-41E8-B4CE-72C47B5A6D3AQ34330035-5F93DFC4-B6BE-42CF-B93D-6A0FAB1851A5Q34352379-FD5102AD-4744-454A-9737-9C537E3615FDQ35590232-8A5238A8-5D4C-4B1E-81F4-73F5A8F68FD6Q35688115-1FCF207A-250B-402A-A70F-1B5AD5F2BFF9Q35748024-54991C41-5D34-40DA-A6ED-73FCCBC33002Q35991894-C126426D-D6DF-458E-82C6-EEE4664A65FAQ36868343-323E3FF0-AAAB-4118-8B99-25FBA57BF86BQ36899777-0AB3B31F-1560-4295-BD0C-5DE722AD94EEQ36915804-9D611AAE-1AEB-4051-BE9F-A9BF6F47D892Q37351584-7F032DA3-918E-4379-87FB-0A684050F51BQ37643585-EADF6627-996C-4B2B-A9B6-A5F81364C1E6Q40969480-8984E307-4210-4AB5-A566-569966B86917Q42364223-5588E5FA-C953-4212-B2AC-239F805272C3Q42844120-7DFD12E3-847E-4C6C-B2E9-EB4B4C3C808BQ47361893-AD3E7365-251E-4486-9DA4-0F607E01E223
P2860
Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Plasma VEGF and soluble VEGF r ...... sfunction and laser treatment.
@ast
Plasma VEGF and soluble VEGF r ...... sfunction and laser treatment.
@en
type
label
Plasma VEGF and soluble VEGF r ...... sfunction and laser treatment.
@ast
Plasma VEGF and soluble VEGF r ...... sfunction and laser treatment.
@en
prefLabel
Plasma VEGF and soluble VEGF r ...... sfunction and laser treatment.
@ast
Plasma VEGF and soluble VEGF r ...... sfunction and laser treatment.
@en
P2093
P1476
Plasma VEGF and soluble VEGF r ...... ysfunction and laser treatment
@en
P2093
P304
P407
P577
2000-07-01T00:00:00Z